PT  - JOURNAL ARTICLE
AU  - Yuan, Cheng Yuan
TI  - Statistical methods for batch screening of input populations by stage and group in COVID-19 nucleic acid testing
AID  - 10.1101/2020.04.02.20050914
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.02.20050914
4099  - http://medrxiv.org/content/early/2020/04/28/2020.04.02.20050914.short
4100  - http://medrxiv.org/content/early/2020/04/28/2020.04.02.20050914.full
AB  - Purpose To screen for COVID-19 patients in immigration using minimal nucleic acid testing (NAT).Methods In the first phase, nasopharyngeal swab samples from the inbound population were numbered and grouped. The samples in the group were mixed together, and a NAT test was performed. When the test result is negative, it means that everyone in the group is not infected and the screening of the group is complete. When the test results were positive, the group moved on to the second stage. In the second stage, all samples in the positive group will be tested individually for NAT.Results The advantages and considerations of the method are discussed. Prevalence in the incoming population was a determinant of the sample size within the group. The lower the incidence, the larger the sample size within the group, the higher the savings in NAT and testing costs.Conclusion This method has significant efficiency and cost advantages in COVID-19 screening. It can also be used to screen other populations, such as community populations and people at high risk of infection, etc.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT12345678Funding StatementThere is no external funding, and there is no conflict of interest.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, models, and code generated or used during the study appear in the submitted article.